Using Toradol for Pain Control After Prophylactic Femoral Nailing
Official title: Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Run by St. Louis University · NCT03823534 · Data updated 2026-11-12
This study is testing whether adding Toradol to opioid pain relief can help patients recovering from surgery on their femur feel better while using fewer narcotics.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | St. Louis University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | February 20, 2019 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT03823534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with femoral shaft or neck bone lesions scheduled for prophylactic intramedullary nailing.
✕Probably not a fit
Patients with concurrent pathologic fractures, significant renal impairment, or those with a history of NSAID allergies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of using Toradol (ketorolac) in addition to opioids for post-operative pain management in patients undergoing prophylactic intramedullary nailing of the femur due to bone lesions. It aims to address the opioid crisis by exploring a multi-modal pain management approach that may reduce reliance on narcotics. The study will compare pain control outcomes between patients receiving both Toradol and opioids versus those receiving only opioids. The unique patient population consists of individuals without fractures, allowing for the safe use of NSAIDs post-operatively.
Why it matters
Potential benefit: If successful, this approach could lead to improved pain management while reducing opioid consumption in post-operative patients.
How similar studies have gone: Previous studies have shown promise in multi-modal pain management strategies, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Femoral Shaft or Neck bone lesion 2. 18 years old or greater 3. Plan to undergo prophylactic intramedullary nailing of one femur Exclusion Criteria: 1. Concurrent pathologic fracture 2. History of advanced renal impairment (eGFR\<30mL/min) 3. History of Peptic Ulcer Disease with bleeding or requiring hospitalization 4. History of NSAID or aspirin allergy 5. Concurrent chemotherapy regimen that prevents NSAID use 6. History of liver disease that precludes use of toradol 7. History of heart failure or cardiovascular disease that precludes toradol usage 8. Pregnancy 9. History of narcotic allergy resulting in anaphylaxis 10. Patients with coagulation disorders or those who require concomitant use of anticoagulant or anti- platelet therapy during the treatment phase of the study. 11. Patients with acetaminophen allergies resulting in anaphylaxis 12. Current use of the medication probenecid 13. Current use of the medication Pentoxifylline 14. History of aspirin induced asthma. 15. Known history of opioid dependence, abuse, or addiction. 16. Bilateral IMN of the femurs
Where it's running
-
Saint Louis University
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: David Greenberg, MD — St. Louis University
- Study coordinator: David Greenberg, MD
- Email: david.greenberg@health.slu.edu
- Phone: 314-617-3410
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored exercise program to improve quality of life for adults with hematologic cancers
This pilot trial tests a personalized 16-week exercise program to see if it’s feasible and helpful for adults with acute myeloid leukemia, lymphoma, or multiple myeloma after first-line treatment.
-
Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia
This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.
-
AI-generated personalized question lists to help people with lymphoma or multiple myeloma prepare for clinic visits.
This study will test whether AI-generated personalized question lists help people with lymphoma or multiple myeloma ask better questions and get more useful information during outpatient appointments.
-
High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau
This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.
-
Improving outcomes for stem cell transplant patients using an intervention website
This study is testing if a special website can help adults with blood cancer feel better and improve their quality of life after a stem cell transplant compared to a regular educational website.
-
Using Whole Body MRI to Improve Cancer Detection
This study is testing if Whole Body MRI can help find bone and soft tissue problems in people with different types of cancer, like lymphoma and advanced prostate and breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.